2008
DOI: 10.1016/j.tcb.2008.04.003
|View full text |Cite
|
Sign up to set email alerts
|

HDAC6: a key regulator of cytoskeleton, cell migration and cell–cell interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

9
419
1
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 449 publications
(432 citation statements)
references
References 67 publications
9
419
1
3
Order By: Relevance
“…Interestingly, both HDAC5 and HDAC7 undergo active nucleocytoplasmic shuttling in response to extracellular signals (McKinsey et al, 2000;Vega et al, 2004), which may allow for fine-tuning of angiogenesis-related genes. In contrast, HDAC6 resides exclusively in the cytoplasm presumably due to its tetradecapeptide repeat domain and its association with cytoskeletal components (Bertos et al, 2004;Valenzuela-Fernández et al, 2008). Consistent with the localization pattern of HDAC6, it mainly participates in cytoskeleton-related activities, independently of histone modification (Boyault et al, 2007;Valenzuela-Fernández et al, 2008).…”
Section: Discussionmentioning
confidence: 59%
See 2 more Smart Citations
“…Interestingly, both HDAC5 and HDAC7 undergo active nucleocytoplasmic shuttling in response to extracellular signals (McKinsey et al, 2000;Vega et al, 2004), which may allow for fine-tuning of angiogenesis-related genes. In contrast, HDAC6 resides exclusively in the cytoplasm presumably due to its tetradecapeptide repeat domain and its association with cytoskeletal components (Bertos et al, 2004;Valenzuela-Fernández et al, 2008). Consistent with the localization pattern of HDAC6, it mainly participates in cytoskeleton-related activities, independently of histone modification (Boyault et al, 2007;Valenzuela-Fernández et al, 2008).…”
Section: Discussionmentioning
confidence: 59%
“…A number of HDAC inhibitors are in clinical development as anticancer agents (Xu et al, 2007), and one of them, suberoylanilide hydroxamic acid, has recently been approved for the treatment of advanced cutaneous T cell lymphoma (Marks, 2007). While most of the HDACs are localized in the nucleus, HDAC6 is a cytoplasmic protein associated with the cytoskeleton and involved in cytoskeleton-related activities (Boyault et al, 2007;Valenzuela-Fernández et al, 2008). There is a growing body of evidence showing that HDAC6 functions at the intersection of the cytoskeleton and cell signaling to regulate cell motility, cell adhesion, and cell-cell interactions (Boyault et al, 2007;Valenzuela-Fernández et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition to a-tubulin, several cytoplasmic proteins including Hsp90 [6,7], cortactin [8], b-catenin [9], peroxiredoxins I and II [10], and Ku70 [11] are regulated in a HDAC6-mediated deacetylation-dependent manner. Strong ubiquitin binding activity [12,13] further adds to the multifunctionality of HDAC6, enabling the regulation of many important processes including cell migration, cell stress response to the cytotoxic accumulation of protein aggregates, and immune synapse formation [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…Histone deacetylase 6 (HDAC6), a cytosolic member of class II HDACs 18 , is responsible for deacetylating both tubulin 19 and tau 16 . Intriguingly, neurons in which HDAC6 were knocked down lose the axonal initial segment (AIS) 20 , a trafficking barrier important for maintaining the polarized localization of axonal proteins, although the mechanism remains unknown.…”
mentioning
confidence: 99%